Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling

Xiaohua Yan1, Ye-Guang Chen

  • 1The State Key Laboratory of Biomembrane and Membrane Biotechnology, School of Life Sciences, Tsinghua University, Beijing, China.

The Biochemical Journal
|January 29, 2011
PubMed

Insights

Transforming growth factor-β (TGF-β) signaling is regulated by Smad7, a key negative regulator. Smad7 antagonizes TGF-β actions and influences development, homeostasis, and diseases like cancer and fibrosis.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Biochemistry

Background:

  • Transforming growth factor-β (TGF-β) is a crucial cytokine involved in numerous cellular functions.
  • TGF-β exerts its effects via membrane receptors and downstream signaling molecules, including Smad proteins.
  • Smad7 is a well-established negative regulator of TGF-β signaling.

Purpose of the Study:

  • To elucidate the multifaceted roles of Smad7 in TGF-β signaling.
  • To understand Smad7's mechanisms of action in both the cytoplasm and nucleus.
  • To highlight Smad7's significance as a cross-talk mediator and its implications in human diseases.

Main Methods:

  • Analysis of Smad7's inhibitory mechanisms.
  • Investigation of Smad7's transcriptional regulation by TGF-β and other growth factors.
  • Review of Smad7's involvement in cellular processes and disease pathogenesis.

Main Results:

  • Smad7 effectively antagonizes TGF-β signaling through diverse cytoplasmic and nuclear mechanisms.
  • Smad7 expression is induced by TGF-β and other growth factors, indicating its role in pathway cross-talk.
  • Altered Smad7 expression is linked to various human diseases, including cancer, fibrosis, and inflammation.

Conclusions:

  • Smad7 is a pivotal negative regulator of TGF-β signaling with broad implications.
  • Smad7's regulatory functions are critical for embryonic development and adult homeostasis.
  • Dysregulation of Smad7 contributes to the pathogenesis of significant human diseases.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...